| 2025-12-10 |
详情>>
内部人交易：
Benedict Peter等共交易2笔
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本1828.09万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.67美元,归母净利润1253.50万美元,同比去年增长-66.64%
|
| 2025-10-22 |
财报披露：
美东时间 2025-10-22 盘后发布财报
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益1.01美元,归母净利润1905.70万美元,同比去年增长-29.34%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益0.49美元,归母净利润940.20万美元,同比去年增长-43.15%
|
| 2025-04-04 |
股东大会：
将于2025-05-19召开股东大会
会议内容 ▼▲
- 1.Elect the eight directors named in the Proxy Statement;
2.Approve the USANA Health Sciences, Inc. 2025 Equity Incentive Plan
3.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the Fiscal Year 2025;
4.Approve, on an advisory basis, our executive compensation, as described in these proxy materials;
5.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2025-03-12 |
详情>>
业绩披露：
2024年年报每股收益2.20美元,归母净利润4203.00万美元,同比去年增长-34.11%
|
| 2025-03-12 |
详情>>
业绩披露：
2022年年报每股收益3.60美元,归母净利润6935.00万美元,同比去年增长-40.47%
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.97美元,归母净利润3757.60万美元,同比去年增长-20.09%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益1.41美元,归母净利润2696.90万美元,同比去年增长-24.4%
|
| 2024-08-06 |
详情>>
业绩披露：
2023年中报每股收益1.85美元,归母净利润3567.50万美元,同比去年增长-14.3%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益0.86美元,归母净利润1653.70万美元,同比去年增长-10.04%
|
| 2024-03-22 |
股东大会：
将于2024-05-06召开股东大会
会议内容 ▼▲
- 1.Elect the eight directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the Fiscal Year 2024;
3.Approve, on an advisory basis, our executive compensation, as described in these proxy materials;
4.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益3.31美元,归母净利润6378.80万美元,同比去年增长-8.02%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益2.44美元,归母净利润4702.20万美元,同比去年增长-16.86%
|
| 2023-03-31 |
股东大会：
将于2023-05-10召开股东大会
会议内容 ▼▲
- 1.Elect the eight directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the Fiscal Year 2023;
3.Approve, on an advisory basis, our executive compensation, as described in these proxy materials;
4.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2022-03-30 |
股东大会：
将于2022-05-09召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the Fiscal Year 2022;
3.Approve, on an advisory basis, our executive compensation, as described in these proxy materials;
4.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-30 |
股东大会：
将于2021-05-10召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the Fiscal Year 2021;
3.Approve, on an advisory basis, our executive compensation, as described in these proxy materials;
4.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2020-03-20 |
股东大会：
将于2020-05-01召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the Fiscal Year 2020;
3.Approve, on an advisory basis, our executive compensation, as described in these proxy materials;
4.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2019-03-22 |
股东大会：
将于2019-05-01召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the Fiscal Year 2019;
3.Conduct an advisory vote on our named executive officer compensation, as described in these proxy materials;
4.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2018-03-23 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.Elect seven directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year 2018;
3.Conduct an advisory vote on our named executive officer compensation, as described in these proxy materials;
4.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2017-03-24 |
股东大会：
将于2017-05-03召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the Proxy Statement;
2.Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year 2017;
3.Approve on an advisory basis the Company's executive compensation, commonly referred to as a "Say on Pay" proposal;
4.Consider a non-binding advisory vote regarding the frequency of submission to shareholders of such advisory "Say on Pay" proposals;
5.Such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|
| 2016-10-25 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2016-03-23 |
股东大会：
将于2016-05-02召开股东大会
会议内容 ▼▲
- 1. To elect seven directors to serve for one year each, until the next Annual Meeting of Shareholders and until a successor is elected and shall qualify;
2. To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year 2016;
3. To consider and act upon such other business as may properly come before the meeting or at any postponement or adjournment thereof.
|